PhD (2006) in Pharmacy (Pharmacology), Universidade de Lisboa
Assistant Professor, Pharmacological Sciences , Faculdade de Farmácia, Universidade de Lisboa
Faculdade de Farmácia, Universidade de Lisboa — Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal
Rui Pinto research is developed at the Pharmacology and Translational Research team (PTR). His work is focused in target identification for/of inflammatory conditions on eg primary (arthritis, Chron’s) or secondary (post stroke, post transplant, ischemia/reperfusion-induced (multi) organ injury, diabetes) etiology. He works, also, in the field of Laboratory Medicine namely in the areas of: Hematology, Clinical Biochemistry, Toxicology and Immunology.
Mateus V, Rocha J, Alves P, Mota-Filipe H, Sepodes B, Pinto R. Thiadiazolidinone-8 Ameliorates Inflammation Associated with Experimental Colitis in Mice. Pharmacology 2018; 101: 35-42.
Aguiar P, Azevedo O, Pinto R, Marino J, Baker R, Cardoso C, Soares J, Hughes, D. New biomarkers defining a novel early stage of Fabry nephropathy: A diagnostic test study. Molecular Genetics and Metabolism 2017; 121: 162-169.
Mateus V, Rocha J, Alves P, Mota‐Filipe H, Sepodes B, Pinto R. Anti‐Inflammatory Effect of Erythropoietin in the TNBS‐induced Colitis. Basic & Clinical Pharmacology & Toxicology 2017; 120: 138-145
García-Lestón J, Roma-Torres J, Vilares M, Pinto R, Prista J, Teixeira JP, Mayan O, Conde J, Pingarilho M, Gaspar JF, Pásaro E, Méndez J, Laffon B. Genotoxic effects of occupational exposure to lead and influence of polymorphisms in genes involved in lead toxicokinetics and in DNA repair. Environment international 2012; 43: 29-36.
Pinto R, Barrento C, Mota-Filipe H, Lima BS. Phenylephrine induces endogenous noradrenaline release in the rat vas deferens through nitric oxide synthase pathway. Pharmacology & Toxicology 2003; 93: 191-196.